Branching Scenario-Based Education in Coronary Artery Disease
ConditionCoronary Arterial Disease (CAD)
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorAbant Izzet Baysal University
About this trial
This randomized controlled trial aims to evaluate the effects of nurse-led branching scenario-based education delivered through virtual reality and tablet on cardiovascular disease risk awareness and adherence to antiplatelet medication in patients with coronary artery disease. Participants will be randomly assigned to a virtual reality education group, a tablet-based education group, or a control group receiving routine hospital education. Cardiovascular disease risk awareness and medication adherence will be assessed before and after the educational intervention and during follow-up.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Aged 18-65 years.
Diagnosed with coronary artery disease.
Newly initiated on antiplatelet therapy.
Conscious and able to communicate.
Disqualifiers
Cognitive impairment or mental illness preventing communication.
Visual or hearing impairment preventing participation in the virtual reality education.
Participation in another clinical study at the same time.
Diagnosis of malignant disease.
Trial design
Design model
Parallel
Treatments tested in this trial
Virtual Reality-Based Branching Scenario Education
BehavioralParticipants will first complete a pre-test assessment. They will then receive nurse-led coronary artery disease education through an interactive, branching scenario-based educational program delivered using a virtual reality (VR) headset. The educational content includes visual, interactive, and scenario-based learning activities, with different learning pathways and feedback based on participants' choices. Following the educational intervention, participants will complete a post-test assessment.
Tablet-Based Branching Scenario Education
BehavioralParticipants will first complete a pre-test assessment. They will then receive nurse-led coronary artery disease education through an interactive, branching scenario-based educational program delivered using a tablet. The educational content includes visual, interactive, and scenario-based learning activities, with different learning pathways and feedback based on participants' choices. Following the educational intervention, participants will complete a post-test assessment.
Treatment groups
54 Participants
are divided into 3 treatment groupsGroup A: control groupNo intervention 0 interventions
Group B: virtual reality educationExperimental treatment 1 intervention
Group C: Tablet EducationExperimental treatment 1 intervention
Trial outcomes
Primary outcomes
1
cardiovascular disease risk awareness assessment scale score
Change in cardiovascular disease risk awareness, assessed using the Turkish validated 22-item Cardiovascular Disease Risk Awareness Assessment Scale (CVD-RAAS). The knowledge domain score ranges from 0 to 8, with higher scores indicating higher knowledge about myocardial infarction and stroke. The total score for the 14-item Likert-type awareness subscales ranges from 14 to 56, with higher scores indicating greater awareness of cardiovascular disease risks, healthier dietary intentions, and higher readiness for behavioral change.
Time frame
baseline and immediately after the educational intervention2
medication adherence report scale score
Change in medication adherence, assessed using the Turkish validated 5-item Medication Adherence Report Scale (MARS-5). Each item is scored on a 5-point Likert scale (1 = always to 5 = never). Total scores range from 5 to 25, with higher scores indicating greater medication adherence.
Time frame
Baseline, immediately after the intervention, and 3 months follow-up3
Cardiovascular Disease Risk Awareness Assessed by the Cardiovascular Disease Risk Awareness Assessment Questionnaire
Cardiovascular disease risk awareness will be assessed using the Turkish version of the Cardiovascular Disease Risk Awareness Assessment Questionnaire (CDRAAQ), a 22-item instrument consisting of an 8-item knowledge section and three subscales: perceived risk of heart attack/stroke, healthy eating intentions, and perceived benefits and intentions to change. The knowledge items are scored as correct or incorrect, with each correct response receiving 1 point. The subscale items are rated on a 4-point Likert scale from 1 (strongly disagree) to 4 (strongly agree), with reverse scoring applied where appropriate. Higher scores indicate greater cardiovascular disease risk awareness, greater knowledge of heart attack and stroke, and greater readiness for health-related behavioral change.
Time frame
Baseline, immediately after the intervention, and 3 months after the intervention.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: